FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

FDA Clears Medtronic’s Radio Frequency System for Nerve Ablation

March 1, 2019
A A

The FDA granted 510(k) clearance for Medtronic’s Accurian radio frequency ablation platform, which is used to remove nerve tissue.

The device is designed to conduct radio frequency ablation of a patient’s nerve tissue, a minimally invasive procedure in which radio waves heat up a small area of nerve tissue to end the transmission of pain signals.

The system uses power and temperature-controlling software to provide consistent, predictable lesion formation.

View today's stories